Nakamura, T., Kawagoe, Y., Matsuda, T., Ueda, Y., Ebihara, I. and Koide, H. (2005) Silent Cerebral Infarction in Patients with Type 2 Diabetic Nephropathy. Effects of Antiplatelet Drug Dilazepdihydrochloride. Diabetes/Metabolism Research and Reviews, 21, 39-43.
http://dx.doi.org/10.1002/dmrr.473

has been cited by the following article:

• TITLE: Silent Cerebral Infarctions in Type II Diabetes Mellitus Patients; Could Brain MRI Be a Routine Investigation?

  AUTHORS: Mohamed Hamdy Ibrahim, Taha Kamel Alloush, Marwa Adel Shaaban, Mohammed Khalid Abdul Rahim, Mohammad Ahmad M. Saad

  KEYWORDS: Prevalence, Silent Brain Infarction, Diabetes Mellitus

  JOURNAL NAME: Open Journal of Medical Imaging, Vol.4 No.3, September 1, 2014

  ABSTRACT: Objective: To study the prevalence of silent cerebral infarction in Type II diabetes mellitus. Patients and Methods: The study was a prospective on 80 patients recruited from neurology, endocrine outpatient clinics. Patients were type II diabetics as described by the American Diabetes Association, 2011 criteria. All patients underwent full metabolic profiles to diagnose diabetes mellitus and MRI brain scans to detect cerebral infarction. Results: Silent cerebral infarctions were detected in 60% of patients (48/80 patients) predominately along periventricular white matter area and subcortical areas (Basal ganglia, Thalamus). Conclusion: Asymptomatic Type II diabetes mellitus patients could have vascular cerebral changes without neurological symptoms. MRI brain scans could be recommended as routine diagnosis (if possible) for early cerebral infarct detection in type II diabetic patients.